Clemens M.F. Dirven

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano et al. · Journal of Clinical Oncology · 2018 · 708 citations

Medicine, Oncology, Pharmacology +17

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis

Maarten M.J. Wijnenga, Pim J. French, Hendrikus J. Dubbink et al. · Neuro-Oncology · 2017 · 331 citations · Full text

Medicine, Oncology, Surgery +17

Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

Celine S. Gathier, Walter M. van den Bergh, Mathieu van der Jagt et al. · Stroke · 2017 · 207 citations · Full text

Medicine, Neurosurgery, Surgery +15

Clinical Feasibility of a Wearable Mixed-Reality Device in Neurosurgery

Fatih Incekara, Marion Smits, Clemens M.F. Dirven et al. · World Neurosurgery · 2018 · 195 citations

Medicine, Neurological Surgery, Neurosurgery +14

Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

Martine L.M. Lamfers, Jacques Grill, Clemens M.F. Dirven et al. · PubMed · 2002 · 186 citations

Medicine, Molecular Biology, Oncology +15